Interest of targeting AgNORs measurement in cycling cells: In vivo cell kinetic evaluation of non-small cell lung cancer

Analytical Cellular Pathology

Volumn 11, Issue 3, 1996, Pages 183-198

  Bigras, Gilbert ^a   Marcelpoil, Raphaël ^a   Brambilla, Elizabeth ^b   Brugal, Gérard ^a  

^a INSTITUT ALBERT BONNIOT   (France)

^b HÔPITAL MICHALLON   (France)

Author keywords

AgNOR; Cell cycle; Ki67; Non small cell lung tumor; Prognosis; Proliferative activity

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME NOR; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; SILVER STAINING;

AGED; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL DIVISION; EVALUATION STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; KINETICS; LUNG NEOPLASMS; MIDDLE AGED; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; SILVER STAINING; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0029738706     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. The cell-division cycle. In: Robertson M, Adams R, eds. Molecular biology of the cell. New York: Garland Publishing, 1995;863-910.
2. Andersen L. Electron microscopy and morphometry of nucleoli in rat neurosecretory cells with stimulated and suppressed secretion. Acta Anatom 1990;138:348-351.
3. Baserga R. Growth in size and cell proliferation. In: The biology of cell reproduction. Cambridge, Massachusetts: Harvard University Press, 1985;103-113.
4. Baserga R. The cell cycle. In: The biology of cell reproduction. Cambridge, Massachusetts: Harvard University Press, 1985;3-21.
5. Baserga R. Tissue growth. In: The biology of cell reproduction. Cambridge, Massachusetts: Harvard University Press, 1985;46-59.
6. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
7. Brugal G. Interpretation of proliferation markers. In: Wield GL, Bartels PH, Rosenthal DL, Schenck U, eds. Compendium on the computerized cytology and histology laboratory. Chicago: Int Acad Cytol Publishers, 1994;234-240.
8. Carbajo S, Orfao A, Vicente, Villardon JL, Carbajo, Perez E. Expression of silver-stained nucleolar organizer regions is coupled to cell cycle in rat thymic cells. Cytometry 1993;14:46-52.
9. Crocker J. Molecular and immunological aspects of cell proliferation. In: Crocker J, eds. Molecular biology in histopathology. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley and Sons, 1994;93-120.
10. Derenzini M, Pession A, Trerè D. Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest 1990;63:137-140.
11. Derenzini M, Sirri V, Trerè D. Nucleolar organizer regions in tumour cells. Cancer Journal 1994;7:71-77.
12. Derenzini M, Thiry M, Goessens G. Ultrastructural cytochemistry of the mammalian cell nucleolus. J Histochem Cytochem 1990;38:1237-1256.
13. Derenzini M, Trerè D. Importance of interphase nucleolar organizer regions in tumor pathology. Virchow Archiv B Cell Pathol 1991;61:1-8.
14. Duchrow M, Gerdes J, Schlüter C. The proliferation-associated Ki-67 protein: definition in molecular terms. Cell Prolif 1994;27:235-242.
15. Gaffney EV, Nardone RM. Nucleolar RNA synthesis in synchronous cultures of strain L-929. Expl Cell Res 1968;53:410-416.
16. Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H. Growth fractions in malignant non-Hodgkin's Iymphomas (NHL) as determined in situ with the monoclonal antibody Ki67. Hematol Oncol 1984;2:365-371.
17. Guillaud P, du Manoir S, Seignerin D. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7). Anal Cell Pathol 1989;1:25-39.
18. Hall PA, Coates PJ. Assessment of cell proliferation in pathology - what next?. Histopathology 1995;26:105-112.
19. Holmgren L, O'Reilly, Folkman J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995;1:149-153.
20. Janmohamed RMI, Murray PG, Crocker J, Leyland MJ. Sequential demonstration of nucleolar organizer regions and ki67 immunolabelling in non-Hodgkin's lymphomas. Clin Lab Haematol 1990;12:395-399.
21. Kim JH, Perez AG. Ribonucleic acid synthesis in synchronously dividing populations of HeLa cells. Nature, London 1965;207:974-975.
22. Lima C, Matsui K, Kitagawa M. Analysis of prognostic factors in patients witn resected peripheral T1 adenocarcinoma of the lung. Pathol Res Pract 1993;189:1149-1153.
23. Mitchison JM. RNA synthesis. The biology of the cell cycle. London, UK: Cambridge University Press, 1971;115-128.
24. Munakata S, Hendricks JB. A multilabeling technique for simultaneous demonstration and quantitation of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue. J Histochem Cytochem 1994;42:789-793.
25. Obeyesekere MN, Herbert JR, Zimmerman SO. A model of the G1 phase of the cell cycle incorporating cyclin E/cdk2 complex and retinoblastoma protein. Oncogene 1995;11:1199-1205.
26. Peeper DS, van der Eb AJ, Zantema A. The G1/S cell cycle checkpoint in eukaryotic cells. Biochimica et Biophysica Acta 1994;1198:215-230.
27. Pfeiffer SE, Tolmach LJ. RNA synthesis in synchronously growing populations of Hela S3 cells. I. Rate of total RNA synthesis and its relationship to DNA synthesis. J Cell Physiol 1968;71:77-94.
28. Picksley SM, Lane DP. p53 and Rb: their cellular roles. Curr Opin Cell Biol 1994;6:853-858.
29. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and in the visualisation of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
30. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 1990;160:93-102.
31. Raymond WA, Leong ASY. Nucleolar organizer regions relate to growth fraction in human breast carcinoma. Hum Pathol 1989;20:741-752.
32. Santisteban MS, Brugal G. Image analysis of in situ cell cycle related changes of PCNA and Ki-67 proliferating antigen expression. Cell Prolif 1994;27:435-453.
33. Schwarting R. Little missed markers and Ki-67. Lab Invest 1993;68:597-599.
34. Scott RJ, Hall PA, Haldane JS, Van Noorden S, Price Y, Lane DP, Wright NA. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 1991;165:173-178.
35. Skog S, Eliasson E, Eliasson E. Correlation between size and position within the division cycle in suspension cultures of Chang liver cells. Cell Tis Kinet 1979;12:501-511.
36. Soomro I, Whimster WF. Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores. J Pathol 1990;162:217-222.
37. Terasima T, Tolmach LJ. Growth and nucleic acid synthesis in synchronously dividing population of HeLa cells. Exp Cell Res 1963;30:342-362.
38. Trerè D, Farabegoli F, Cancellieri A, Ceccarelli C, Eusebi V, Derenzini M. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining. J Pathol 1991;165:53-59.
39. Trerè D, Pession A, Derenzini M. The silver stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res 1989;184:131-137.
40. Van Dierendonck JH, Keijzer R, Cornelisse CJ, Van de Velde CJH. Nuclear distribution of the ki-67 antigen during the cell cycle: comparison with the growth fraction in human breast cancer cells. Cancer Res 1989;49:2999.
41. Wachtler F, Stahl A. The nucleolus: a structural and functional interpretation. Micron 1993;24:473-505.
42. Zetterberg A, Killander D. Quantitative cytophotometric and autoradiographic studies on the rate of protein synthesis during interphase in mouse fibroblasts in vitro. Exp Cell Res 1965;40:1-11.